Unlike previously studied biomarkers such as TP53 or EGFR [11, 12], which have limitations in specificity due to their broader involvement in other cancer types and pathways, COL3A1, COL4A1, COL5A2, and CXCL8 appear to offer more targeted insights into the disease. Here, CXCL8 is linked to cancer.